J Korean Med Sci.  2010 Feb;25(2):230-234. 10.3346/jkms.2010.25.2.230.

Ovarian Cancer during Pregnancy: Clinical and Pregnancy Outcome

• Kwon YS
• Mok JE
• Lim KT
• Lee IH
• Kim TJ
• Lee KH
• Shim JU

• KMID: 1779252
• DOI: http://doi.org/10.3346/jkms.2010.25.2.230

Abstract

The aim of this study is to evaluate the clinical feature and pregnancy outcome in patients with ovarian cancer diagnosed during pregnancy. We retrospectively analyzed the medical records of 27 patients diagnosed with ovarian cancer during pregnancy at Cheil General Hospital & Women's Healthcare Center from January 1996 to December 2006. Mean age of the patients was 29.1 yr (range 23-40), and a mean follow-up period was 57 months (range 7-112 months). Of 27 patients, 15 (55.5%) had borderline malignancies, 7 (25.9%) had epithelial malignancies and 5 (18.6%) had germ cell tumors. A total of 26 patients received a conservative surgery preserving pregnancy. The mean time for surgical intervention during pregnancy was 20 weeks of gestational age. Of the 27 patients, 26 had full term delivery of a healthy baby without any congenital malformation. Only one patient with epithelial ovarian cancer had a relapse at 19 months after the first conservative operation with adjuvant chemotherapy. There were few data for managing patients with ovarian cancer diagnosed during pregnancy. This study results could help establish a guideline for management of ovarian malignancy complicating pregnancy.

Keyword

Ovarian Neoplasms; Pregnancy; Conservative Surgery

MeSH Terms

Adult
Female
Gestational Age
Humans
Neoplasms, Germ Cell and Embryonal/*diagnosis/pathology/secondary
Neoplasms, Glandular and Epithelial/*diagnosis/pathology/secondary
Ovarian Neoplasms/*diagnosis/pathology/surgery
Pregnancy
Pregnancy Complications, Neoplastic/*diagnosis/pathology/surgery
*Pregnancy Outcome
Retrospective Studies
Term Birth

Reference

1. Farahmand SM, Marchetti DL, Asirwatham JE, Deway MR. Ovarian endodermal sinus tumor associated with pregnancy: review of the literature. Gynecol Oncol. 1991. 41:156–160.

2. Whitecar MP, Turner S, Higby MK. Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management. Am J Obstet Gynecol. 1999. 181:19–24.

3. Jacob JH, Stringer CA. Diagnosis and management of cancer during pregnancy. Semin Perinatol. 1990. 14:79–87.

4. Zanotti KS, Belinson JL, Kennedy AW. Treatment of gynecologic cancers in pregnancy. Semin Oncol. 2000. 27:686–698.

5. Lavery J, Koontz WL, Layman L, Shaw L, Gumpel U. Sonographic evaluation of the adnexa during early pregnancy. Surg Gynecol Obstet. 1986. 163:319–323.

6. Hogston P, Lilford RJ. Ultrasound study of ovarian cysts in pregnancy: prevalence and significance. Br J Obstet Gynaecol. 1986. 93:625–628.

7. Hopkins MP, Duchon MA. Adnexal surgery in pregnancy. J Reprod Med. 1986. 31:1035–1037.

8. Elit L, Bocking A, Kenyon C, Natale R. An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol. 1999. 72:123–127.

9. Dgani R, Shoham Z, Atar E, Zosmer A, Lancet M. Ovarian carcinoma during pregnancy: a study of 23 cases in Israel between the years 1960 and 1984. Gynecol Oncol. 1989. 33:326–331.

10. Copeland LJ, Landon MB. Gabbe SG, Niebyl JR, Simpson JL, editors. Malignant disease in pregnancy. Obstetrics, normal and problem pregnancies. 1996. 3rd ed. New York, NY: Churchill Livingstone;1155–1181.

11. Behtash N, Karimi Zarchi M, Modares Gilani M, Ghaemmaghami F, Mousavi A, Ghotbizadeh F. Ovarian carcinoma associated with pregnancy: a clinicopathologic analysis of 23 cases and review of the literature. BMC Pregnancy Childbirth. 2008. 8:3.

12. Bakri YN, Ezzat A, Akhtar , Dohami , Zahrani . Malignant germ cell tumors of the ovary. Pregnancy considerations. Eur J Obstet Gynecol Reprod Biol. 2000. 90:87–91.

13. Williams SD, Gershenson DM, Horowitz CJ. Hoskins WJ, Perez CA, Young RC, editors. Ovarian germ-cell tumors. Principles and practice of gynecologic oncology edition. 1996. Philadelphia: PA: Lippincot;987–1001.

14. Dudkiewicz J, Kowalski T, Grzonka D, Czarnecki M. Ovarian tumors in pregnancy. Ginekol Pol. 2002. 73:342–345.

15. Pitynski K, Basta A, Szczudrawa A, Oplawski M. Ovarian tumors in pregnancy in the material of the Department of Gynecology and Oncology Collegium Medicum of Jagiellonian University in Cracow. Ginekol Pol. 2002. 73:371–375.

16. Ueda M, Ueki M. Ovarian tumors associated with pregnancy. Int J Gynaecol Obstet. 1996. 55:59–65.

17. Agarwal N, Parul , Kriplani A, Bhatla N, Gupta A. Management and outcome of pregnancies complicated with adnexal masses. Arch Gynecol Obstet. 2003. 267:148–152.

18. Grendys EC Jr, Barnes WA. Ovarian cancer in pregnancy. Surg Clin North Am. 1995. 75:1–14.

19. Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF. Malignant germ cell tumors of the ovary. Obstet Gynecol. 2000. 95:128–133.

20. Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer. 1998. 82:141–146.

21. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-time follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer. 1996. 78:278–286.

22. Donnez J, Munschke A, Berliere M, Piarard C, Jadou P, Smets M, Squifflet J. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril. 2003. 79:1216–1221.

23. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med. 1992. 152:573–576.

24. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol. 1989. 16:337–346.

25. Arango HA, Kalter CS, Decesare SL, Fiorica JV, Lyman GH, Spellacy WN. Management of chemotherapy in a pregnancy complicated by a large neuroblastoma. Obstet Gynecol. 1994. 84:665–668.

26. Horbelt D, Delmore J, Meisel R, Cho S, Roberts D, Logan D. Mixed germ cell malignancy of the ovary concurrent with pregnancy. Obstet Gynecol. 1994. 84:662–664.

27. Huang HP, Fang CN, Kan YY. Chemotherapy for ovarian mucinous cystadenocarcinoma during pregnancy: a case report. Eur J Gynaecol Oncol. 2004. 25:635–636.

28. Bayhan G, Aban M, Yayla M, Gul T, Yaldiz M, Erden AC. Cisplatinum combination chemotherapy during pregnancy for mucinous cystadenocarcinoma of the ovary. Case report. Eur J Gynaecol Oncol. 1999. 20:231–232.

29. Mendez LE, Mueller A, Salom E, Gonzalez-Quintero VH. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol. 2003. 102:1200–1202.

30. Sood AK, Shahin MS, Sorosky JI. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol. 2001. 83:599–600.

31. Zhao XY, Huang HF, Lian LJ, Lang JH. Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature. Int J Gynecol Cancer. 2006. 16:8–15.